The Beauty Health Company Stock Price, News & Analysis

The Beauty Health Company (NASDAQ:SKIN) announces its second annual GLOWvolution tour, starting May 20 in Fort Worth, TX. This mobile spa will visit five cities, offering complimentary HydraFacial treatments. Featuring 11 treatment chairs and additional outdoor setups, the tour aims to engage consumers and enhance brand visibility. The tour also allows participants to share their experiences on social media. With a growing footprint of 21,719 HydraFacial Delivery Systems in over 90 countries, the company is focused on democratizing skincare solutions.

The Beauty Health Company (NASDAQ:SKIN) has announced a partnership with JLo Beauty, launching the HydraFacial x JLo Beauty Booster. This innovative treatment, inspired by the 'JLo Glow,' features ingredients like Olive Leaf Extract, Fermented Adaptogens, and Hygroplex HHG to enhance skin radiance and hydration. The Booster will be available in the U.S. starting September 2022, promising customized skincare experiences through HydraFacial's existing treatment solutions. CEO Andrew Stanleick expressed excitement about the collaboration, aiming to elevate skin health for consumers.

Beauty Health Company (NASDAQ:SKIN) reported strong Q1 2022 financial results, with net sales reaching $75.4 million, a 58.6% increase from Q1 2021. Key drivers included the successful launch of the Syndeo delivery system, contributing $41.6 million in sales. Gross profit stood at $51.9 million with a gross margin of 68.9%.

Despite a net income of $32.5 million, the company incurred an adjusted net loss of $8.5 million. Management raised fiscal 2022 guidance for net sales to $330 million–$340 million.

The Beauty Health Company (NASDAQ: SKIN) appointed Amy Juaristi as Head of Corporate Affairs, a new position aimed at enhancing strategic communications. With over two decades in beauty and healthcare, Juaristi previously led corporate affairs at Coty and has experience with brands like Zocdoc and Chobani. CEO Andrew Stanleick expressed enthusiasm about her leadership, highlighting her ability to effectively tell the stories of growth-driven brands. The company aims to strengthen its position in the beauty health category as it expands its global reach.

The Beauty Health Company (NASDAQ:SKIN) will report its first quarter 2022 financial results after market close on May 10, 2022. A conference call will follow at 4:30 p.m. Eastern Time to discuss these results. The company emphasizes its innovative approach in the beauty and aesthetics market with its flagship brand, HydraFacial, used in over 20,000 installations across 90 countries. This non-invasive treatment has democratized skincare, providing millions of consumer experiences annually.

The Beauty Health Company (NASDAQ:SKIN) will hold its 2022 Annual Stockholders’ Meeting on June 28, 2022, at 2:00 p.m. Eastern Time, in a virtual-only format. Stockholders can attend via live audio webcast, with no physical location available. Voting options include electronic, mail, or phone prior to the meeting. The record date for eligible stockholders is April 29, 2022. The proxy statement will be filed in mid-May, detailing how to access the meeting and vote.

The Beauty Health Company (NASDAQ:SKIN) has launched HydraFacial Syndeo, a new digitally connected device aimed at enhancing consumer and provider experiences. Available in the US, this upgrade integrates technology and data to offer personalized beauty health services. Syndeo simplifies data collection, enabling providers to understand consumer preferences better. The device retains the signature HydraFacial 3-step experience while allowing for integration with other therapeutic devices. This innovation is expected to strengthen customer relationships and increase consumer activation.

The Beauty Health Company (NASDAQ: SKIN) announced that CEO Andrew Stanleick and CFO Liyuan Woo will present at two upcoming investor conferences. The 43rd Annual Institutional Investors Conference hosted by Raymond James is scheduled for March 8, 2022, at 4:35 p.m. ET. Following that, they will participate in the 5th Annual Consumer Growth Conference by DA Davidson on March 10, 2022, at 8:00 a.m. ET. Presentations will be available on their investor relations website.

BeautyHealth (NASDAQ: SKIN) reported Q4 2021 net sales of $77.9 million, a 105.6% increase from Q4 2020. For FY 2022, the company expects net sales between $320 million to $330 million and adjusted EBITDA around $50 million. Despite a net loss of $17.3 million in Q4 2021, adjusted EBITDA rose to $8.5 million, up from $3.6 million in Q4 2020. Cash and equivalents surged to $901.9 million, largely from a $638.7 million convertible senior notes offering. The company aims to leverage its investments and achieve historical profitability margins by 2023.